ESR1 and breast cancer: As previously shown for MDA-MB-231 BC cells, we found a significant increase of YFP-Y537S receptor transcriptional activity as compared to that of YFP-WT ERα and this induction was reduced upon exposure to compound 19 (Figure 4B).